Context Therapeutics Inc. (CNTX): Total Liabilities
$8.02M
As of 2025-12-31
$7.96M
As of 2026-06-30
+35.7%
3-year compound annual growth
-3.6%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.02M | +180.4% | 2026-03-23, Balance as of period end |
| 2024-12-31 | $2.86M | -31.8% | 2026-03-23, Balance as of period end |
| 2023-12-31 | $4.19M | +30.7% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $3.21M | +5.7% | 2024-03-21, Balance as of period end |
| 2021-12-31 | $3.03M | -68.5% | 2023-03-22, Balance as of period end |
| 2020-12-31 | $9.62M | n/a | 2022-03-23, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | 2025-12-31 | $8.02M | +180.4% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $9.90M | -84.6% |
| Werewolf Therapeutics, Inc. (HOWL) | 2025-12-31 | $44.59M | -16.7% |
| Grace Therapeutics, Inc. (GRCE) | 2026-03-31 | $2.76M | -48.8% |
| Corvus Pharmaceuticals, Inc. (CRVS) | 2025-12-31 | $9.91M | -72.7% |
| Aldeyra Therapeutics, Inc. (ALDX) | 2025-12-31 | $27.81M | -17.2% |
| Incannex Healthcare Inc. (IXHL) | 2026-06-30 | $5.61M | -20.6% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $50.21M | +12.4% |
| Rallybio Corp (RLYB) | 2025-12-31 | $4.30M | -33.3% |
Compare CNTX, SPRO, HOWL, GRCE side by side · Screen every company in Pharmaceutical Preparations ↗